Baird’s Edwards Lifesciences EW Stock Holding History

Baird’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$1.24M	Buy	52,296 +12,618	+32%	+$283K	0.01%	692
2014 Q4	$843K	Buy	+39,678	New	+$797K	0.01%	780
2014 Q2	–	Sell	-963,780	Closed	-$11.9M	–	1165
2014 Q1	$11.9M	Buy	963,780 +450,396	+88%	+$5.2M	0.17%	154
2013 Q4	$5.63M	Sell	513,384 -117,042	-19%	-$1.32M	0.1%	230
2013 Q3	$7.32M	Buy	630,426 +167,046	+36%	+$1.95M	0.14%	196
2013 Q2	$5.19M	Buy	+463,380	New	+$5.48M	0.1%	231

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Baird's EW Position: Q1 2015 in Review

Baird increased its Edwards Lifesciences (EW) stake by 32% in Q1 2015, buying an estimated $283K and bringing the position to 52,296 shares worth $1.24M. The position accounts for 0.01% of the portfolio, ranked #692.

Baird first reported a position in EW in Q2 2013 and has held it in 6 quarters since. The position peaked at $11.9M in Q1 2014. 575 funds tracked by Wall St. Rank hold EW as of Q1 2015.

Baird held 52,296 shares of Edwards Lifesciences worth $1.24M as of Q1 2015.
Baird bought 12,618 Edwards Lifesciences shares in Q1 2015, an estimated $283K.
Edwards Lifesciences made up 0.01% of Baird's portfolio in Q1 2015, its #692 holding.
Baird first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 6 quarters since.
Baird's Edwards Lifesciences position peaked at $11.9M in Q1 2014.
575 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2015.

Based on Baird's 13F filing for Q1 2015, filed 13 May 2015.